Episodes 121-135 of 253
Evaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
Clinician's RoundtableEvaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart MattersImproving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Heart MattersEarly Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Project Oncology®Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiersBridging the Gap: New Consensus Recommendations for Adult DMD Care
Optimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
On the Frontlines of C3GOptimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
- advertisement
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiersThe Complexities of DMD: Optimizing Multidisciplinary Care
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Patient Counseling in C3GN: From Disease Education to Shared Decision-Making
On the Frontlines of C3GPatient Counseling in C3GN: From Disease Education to Shared Decision-Making
- advertisement
Unmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
Living RheumUnmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiersExploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Challenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
On the Frontlines of C3GChallenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
